Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$162.77 USD

162.77
994,723

+0.07 (0.04%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Clorox (CLX) Lags Q2 Earnings Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of -15.38% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Church & Dwight (CHD) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Church & Dwight (CHD) delivered earnings and revenue surprises of 10.34% and 1.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Clorox (CLX) Q2 Earnings Expected to Decline

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox (CLX) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Clorox (CLX) Q2 results are likely to reflect impacts of unfavorable price mix, lower shipments, and elevated logistics and commodity costs. Its IGNITE strategy and productivity initiatives bode well.

Rajani Lohia headshot

4 Soaps & Cleaning Materials Stocks to Watch Amid Cost Woes

by Rajani Lohia

Elevated logistics, input and manufacturing costs have been eroding margins for several soap and cleaning materials companies amid aggravated supply-chain woes. Players like Procter & Gamble (PG), Colgate (CL), Church & Dwight (CHD) and Clorox (CLX) are expected to benefit from innovation.

Clorox (CLX) Down 1.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Church & Dwight (CHD) Inks Deal to Acquire TheraBreath Brand

by Zacks Equity Research

Church & Dwight (CHD) inks an agreement to acquire leading mouthwash brand, TheraBreath. The deal, valued at $580 million, is expected to close in fourth-quarter 2021.

Company News for Nov 3, 2021

by Zacks Equity Research

Companies In The News Are: CLX, UAA, CMI, ZBRA.

Clorox (CLX) Q1 Earnings and Sales Top Estimates, Decline Y/Y

by Zacks Equity Research

Clorox (CLX) Q1 results gain from strength across the portfolio and robust demand. Lower volume and unfavorable price mix have been headwinds.

Mark Vickery headshot

New All-Time Closing Highs for Dow, Nasdaq, S&P

by Mark Vickery

Market indexes were once again higher across the board this Monday, with three of the four majors reaching fresh all-time closing highs.

Clorox (CLX) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 19.80% and 6.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Factors Likely to Influence Clorox (CLX) in Q1 Earnings

by Zacks Equity Research

Elevated manufacturing and logistics costs are expected to have hurt Clorox's (CLX) Q1 bottom line. Yet, its IGNITE strategy and cost-saving initiatives are likely to have been encouraging.

Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox (CLX) Up 3.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Industry Outlook Highlights: Procter & Gamble, Unilever, Church & Dwight, Colgate-Palmolive and Clorox Co

by Zacks Equity Research

Zacks Industry Outlook Highlights: Procter & Gamble, Unilever, Church & Dwight, Colgate-Palmolive and Clorox Co

Vidya Nair headshot

3 Soaps & Cleaning Materials Stocks to Wash Away Industry Blues

by Vidya Nair

Moderation in demand and rise in input costs are headwinds for several soap and cleaning materials companies. Nonetheless, efforts to boost offerings are aiding players like Procter & Gamble (PG), Unilever (UL) and Church & Dwight (CHD).

Apple, Clorox, AMC, Planet Fitness and RealReal highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Apple, Clorox, AMC, Planet Fitness and RealReal highlighted as Zacks Bull and Bear of the Day

Benjamin Rains headshot

Bear of the Day: The Clorox Company (CLX)

by Benjamin Rains

Clorox was one of the early coronavirus stars both in the real economy and the stock market. But the maker of disinfectant wipes and many other consumer products has seen its stock price tumble in the past year...

Clorox (CLX) Dips on Q4 Earnings & Sales Miss, Gives FY22 View

by Zacks Equity Research

Lower shipments from the last year's peak, unfavorable price mix, and higher operating and commodity costs mar Clorox's (CLX) Q4 results. It outlines the view for fiscal 2022.

Clorox (CLX) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of -26.36% and -6.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Clorox (CLX) This Earnings Season?

by Zacks Equity Research

Clorox (CLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Clorox (CLX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.

Will Clorox (CLX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Earnings Preview: Clorox (CLX) Q4 Earnings Expected to Decline

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox (CLX) Expands Portfolio With Hamilton Beach Deal

by Zacks Equity Research

Clorox (CLX) to expand its surface and air disinfecting products through its latest multi-year licensing deal with Hamilton Beach Brands. Also, this is in line with the company's IGNITE plan.